NCT02651155View on ClinicalTrials.gov

Lubiprostone for the Treatment of Chronic Idiopathic Constipation

PHASE3CompletedINTERVENTIONAL

Enrollment

204

Participants

Timeline

Start Date

March 2, 2016

Primary Completion Date

January 11, 2017

Study Completion Date

January 11, 2017

Conditions

Constipation

Interventions

DRUG

Lubiprostone

Lubiprostone capsules

DRUG

Placebo

Lubiprostone placebo-matching capsules

Trial Locations (12)

Unknown

Saint Petersburg

Barnaul

Kazan'

Kemerovo

Krasnodar

Moscow

Novosibirsk

Omsk

Saint Petersburg

Samara

Ulyanovsk

Yaroslavl

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY